减少急诊与基层毛细支气管炎不必要治疗的质量改进措施
该质量改进项目覆盖2016-2017和2017-2018两个季节,在基层和儿科急诊实施循证方案、宣传海报、互动培训及每周处方反馈。结果显示急诊沙丁胺醇处方率从13.8%降至9.1%,基层沙丁胺醇、激素和抗生素处方率均显著下降,且控制指标无显著变化。
要点
- 急诊沙丁胺醇处方率从13.8%降至9.1%(p<0.01),肾上腺素无显著变化。
- 基层沙丁胺醇处方率从38.3%降至15.9%,激素从12.9%降至3.6%,抗生素从29.6%降至9.5%(均p<0.01)。
- 急诊就诊、住院、分诊级别、停留时间、ICU入住及非计划重返住院等控制指标无显著变化。
核心结论
- 该质量改进措施安全减少了急性毛细支气管炎的不必要治疗。
- 基层与急诊协作可能是成功的重要因素。
研究设计与样本
- 质量改进项目,涉及2016-2017(干预前)和2017-2018(干预后)两个季节。
- 纳入1878次急诊就诊和1192次基层就诊,其中干预后分别为855次(44.5%)和534次(44.7%)。
主要发现
- 急诊沙丁胺醇处方率从13.8%(95%CI 11.8%至16%)降至9.1%(95%CI 7.3%至11.2%)(p<0.01)。
- 急诊肾上腺素处方率从10.4%(95%CI 8.6%至12.4%)降至9%(95%CI 7.2%至11.1%),无统计学意义。
- 基层沙丁胺醇处方率从38.3%(95%CI 34.6%至42.0%)降至15.9%(95%CI 12.9%至19.5%)(p<0.01)。
- 基层激素处方率从12.9%(95%CI 10.5%至15.7%)降至3.6%(95%CI 2.2%至5.7%)(p<0.01)。
- 基层抗生素处方率从29.6%(95%CI 26.2%至33.2%)降至9.5%(95%CI 7.2%至12.5%)(p<0.01)。
关键数值与推荐
- 干预措施包括分发循证方案、信息海报和「毛细支气管炎,少即是多」徽章。
- 还开展互动会议,并向儿科医生提供每周支气管扩张剂处方报告。
临床怎么用
- 在基层和急诊推行循证方案、宣传材料及处方反馈,可安全减少沙丁胺醇、激素和抗生素的不必要使用。
- 加强基层与急诊协作有助于成功实施减少不必要治疗的干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We performed a quality improvement initiative to reduce unnecessary treatments for acute bronchiolitis (AB) in primary care (PC) and the referral paediatric emergency department (ED). The quality improvement initiative involved two seasons: 2016-2017 (preintervention) and 2017-2018 (postintervention). We distributed an evidence-based protocol, informative posters and badges with the slogan 'Bronchiolitis, less is more'. We also held interactive sessions, and paediatricians received weekly reports on bronchodilator prescription. The main outcome was the percentage of infants prescribed salbutamol. Secondary outcomes were epinephrine, antibiotic and corticosteroid prescription rates. Control measures were ED visit and hospitalisation rates, triage level, length of stay, intensive care admission and unscheduled returns with admission. We included 1878 ED and 1192 PC visits of which 855 (44.5%) and 534 (44.7%) occurred in the postintervention period, respectively. In the ED, salbutamol and epinephrine prescription rates fell from 13.8% (95% CI 11.8% to 16%) to 9.1% (95% CI 7.3% to 11.2%) (p<0.01) and 10.4% (95% CI 8.6% to 12.4%) to 9% (95% CI 7.2% to 11.1%) (n.s.), respectively. In PC, salbutamol, corticosteroid and antibiotic prescription rates fell from 38.3% (95% CI 34.6% to 42.0%) to 15.9% (95% CI 12.9% to 19.5%) (p<0.01), 12.9% (95% CI 10.5% to 15.7%) to 3.6% (95% CI 2.2% to 5.7%) (p<0.01) and 29.6% (95% CI 26.2% to 33.2%) to 9.5% (95% CI 7.2% to 12.5%) (p<0.01), respectively. No significant variations were noted in control measures. We safely decreased the use of unnecessary treatments for AB. Collaboration between PC and ED appears to be an important factor for success.
引用
- Montejo M, Paniagua N, Saiz-Hernando C, et al. Initiatives to reduce treatments in bronchiolitis in the emergency department and primary care. Arch Dis Child. 2019. PMID: 31666241. doi:10.1136/archdischild-2019-318085
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。